Sterling Biotech reports standalone net loss of Rs 112.24 crore in the March 2017 quarter

Sales decline 19.88% to Rs 90.63 crore

Net Loss of Sterling Biotech reported to Rs 112.24 crore in the quarter ended March 2017 as against net loss of Rs 86.27 crore during the previous quarter ended March 2016. Sales declined 19.88% to Rs 90.63 crore in the quarter ended March 2017 as against Rs 113.12 crore during the previous quarter ended March 2016.

For the full year,net loss reported to Rs 412.45 crore in the year ended March 2017 as against net loss of Rs 450.47 crore during the previous year ended March 2016. Sales declined 29.69% to Rs 368.43 crore in the year ended March 2017 as against Rs 523.99 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales90.63113.12 -20 368.43523.99 -30 OPM %6.4415.19 -4.4913.80 - PBDT-92.15-65.72 -40 -353.24-342.48 -3 PBT-157.69-131.93 -20 -616.79-687.62 10 NP-112.24-86.27 -30 -412.45-450.47 8

Powered by Capital Market - Live News